Aurinia Pharmaceuticals (AUPH) FCF Margin (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) posted FCF Margin of 41.85% for Q1 2026, down 29.33% on a QoQ basis from 59.22% in Q4 2025, and up 3980.0% year-over-year from 1.03% in Q1 2025.
Aurinia Pharmaceuticals (AUPH) FCF Margin (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' FCF Margin history runs 7 years deep, the most recent figure standing at 41.85% for Q1 2026.
- Quarterly FCF Margin rose 3980.0% year-over-year to 41.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 56.19% (up 3019.0% YoY) and the FY2025 annual result came in at 48.18%, up 2929.0% from the prior year.
- FCF Margin was 41.85% for Q1 2026 at Aurinia Pharmaceuticals, down from 59.22% in the prior quarter.
- Across five years, FCF Margin topped out at 64.26% in Q2 2025 and bottomed at 216.53% in Q1 2022.
- A 5-year average of 6.16% and a median of 25.32% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin jumped 561629 bps — and 2023, when it sank 340 bps.
- Aurinia Pharmaceuticals' FCF Margin stood at 36.03% in 2022, then retreated by 9 bps to 32.63% in 2023, then soared by 54 bps to 50.37% in 2024, then gained by 18 bps to 59.22% in 2025, then retreated by 29 bps to 41.85% in 2026.
- Business Quant data shows AUPH's FCF Margin at 41.85% in Q1 2026, 59.22% in Q4 2025, and 60.5% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | 41.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.85% |
| Dec 31, 2025 | 59.22% |
| Sep 30, 2025 | 60.50% |
| Jun 30, 2025 | 64.26% |
| Mar 31, 2025 | 2.05% |
| Dec 31, 2024 | 50.37% |
| Sep 30, 2024 | 25.32% |
| Jun 30, 2024 | 27.48% |
| Mar 31, 2024 | -37.00% |
| Dec 31, 2023 | 32.63% |
| Sep 30, 2023 | -24.16% |
| Jun 30, 2023 | -8.03% |
| Mar 31, 2023 | -92.09% |
| Dec 31, 2022 | 36.03% |
| Sep 30, 2022 | -27.61% |
| Jun 30, 2022 | -99.00% |
| Mar 31, 2022 | -216.53% |
| Dec 31, 2021 | -104.13% |
| Sep 30, 2021 | -298.29% |
| Jun 30, 2021 | -626.57% |